Entries by Phil Case

AnPac Bio Announces Equity Investment from Keystone Capital Partners for up to $7 Million

FOR IMMEDIATE RELEASE AnPac Bio Announces Equity Investment from Keystone Capital Partners for up to $7 Million San Jose, CA, October 1, 2020 – AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the United States, announced today that the Company has entered […]

AnPac Bio Receives Major Immunology Testing Contract

FOR IMMEDIATE RELEASE AnPac Bio Receives Major Immunology Testing Contract San Jose, CA, September 15, 2020 – AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the United States focused on early cancer screening and detection, announced today that the Company entered into […]

AnPac Bio Reports First Six Months of 2020 Financial Results

AnPac Bio Reports First Six Months of 2020 Financial Results SAN JOSE, Calif., September 10, 2020 (GLOBE NEWSWIRE) — AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the United States, announced today its financial results for the six months ended June 30, […]

AnPac Bio Announces Positive Results from a Multi-Year Lung Cancer Prognosis and Recurrence Clinical Study

FOR IMMEDIATE RELEASE AnPac Bio Announces Positive Results from a Multi-Year Lung Cancer Prognosis and Recurrence Clinical Study San Jose, CA, September 4, 2020 – AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the United States, announced today positive results from a […]

AnPac Bio Philadelphia Lab Gains U.S. CLIA Lab Certification

FOR IMMEDIATE RELEASE AnPac Bio Philadelphia Lab Gains U.S. CLIA Lab Certification San Jose, CA, August 24, 2020 – AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the United States announced today that the company received a certificate of registration this month […]

AnPac Bio Opens US Philadelphia Lab Operations

FOR IMMEDIATE RELEASE AnPac Bio Opens US Philadelphia Lab Operations San Jose, CA, August 11, 2020 – AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the United States, announced today that the Company has commenced operations of its new Philadelphia lab, with […]

AnPac Bio Validating Approved COVID-19 Antibody Test

FOR IMMEDIATE RELEASE AnPac Bio Validating Approved COVID-19 Antibody Test San Jose, CA, August 7, 2020 – AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the United States announced today that the Company has been validating an approved COVID-19 antibody test, which […]

AnPac Bio Announces Preliminary Results From Prospective Trials Indicating Early-Stage Cancer Screening Effectiveness

FOR IMMEDIATE RELEASE AnPac Bio Announces Preliminary Results From Prospective Trials Indicating Early-Stage Cancer Screening Effectiveness San Jose, CA, August 4, 2020 – AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the United States focused on early cancer screening and detection, announced […]

AnPac Bio Completes Over 180,000 CDA-Based Cancer Risk Assessment Tests

AnPac Bio Completes Over 180,000 CDA-Based Cancer Risk Assessment Tests San Jose, CA, July 29, 2020 – AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (ANPC), a biotechnology company with operations in China and the United States focused on early cancer screening and detection, announced today it had completed over 180,000 Cancer […]

©2021 Anpac Bio-Medical Science Co., Ltd.